Cogent Biosciences, Inc. Common Stock (COGT) is a publicly traded Healthcare sector company. As of November 5, 2026, COGT trades at $29.99 with a market cap of $5.46B and a P/E ratio of -14.24. COGT moved -6.18% today. Year to date, COGT is -13.75%; over the trailing twelve months it is +104.91%. Its 52-week range spans $3.72 to $43.73. Analyst consensus is strong buy with an average price target of $54.88. Rallies surfaces COGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover COGT: 0 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $54.88.
| Metric | Value |
|---|---|
| Price | $29.99 |
| Market Cap | $5.46B |
| P/E Ratio | -14.24 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.73 |
| 52-Week Low | $3.72 |
| Volume | 2.32M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-328.94M |
| Gross Margin | 0.00% |
9 analysts cover COGT: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.88.